Skip to content

Alto Neuroscience ANRO Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-38.9%-0.8pp-41.8%-45%-42.8%-38%
Return on assets-33.2%-0.1pp-34.9%+11.6pp-36.8%-36.5%-33.1%
Liquidity
Current ratio20.5×-2.0×15.7×-1.2×15.4×+2.3×18.4×-1.4×22.5×-3.5×
Quick ratio20.5×-2.0×15.7×-1.2×15.4×+2.3×18.4×-1.4×22.5×-3.5×
Cash ratio20.1×-2.1×15.6×-1.2×15.3×+2.3×18.2×-1.5×22.2×-3.5×
Leverage
Debt-to-equity0.1×-0.1×0.1×0.0×0.2×+0.1×0.2×+0.1×0.2×+0.1×
Debt-to-assets0.1×-0.1×0.1×0.0×0.2×+0.1×0.2×+0.1×0.1×+0.1×
Interest coverage-32.2×+10.7×-26.9×+23.0×-29.8×+15.6×-36.5×+1.9×-43×-10.6×
Per Share
Book value per share$7.40+43.9%$5.24-14.9%$4.12-32.8%$4.56-31.8%$5.14-53.1%
Valuation
Market capitalization$874.19M+1,335%$552.98M+385%$108.85M-64.7%$67.68M-76.4%$58.48M-85.8%
Enterprise value$630.81M-940%$397.73M+1,120%-$4.07M-103%-$55.1M-153%-$77.55M-136%
Price / book3.6×+3.2×3.7×+2.9×-0.9×0.5×-1.1×0.4×-1.7×
Free cash flow yield-7.2%+82.9pp-9.4%+34.0pp-49.4%-33.9pp-83.7%-68.7pp-93.8%-84.7pp
Earnings yield-8.5%+95.2pp-11.4%+42.4pp-57.2%-38.6pp-95.8%-78.5pp-108%-97.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Alto Neuroscience's ratios come from?
Every ratio is computed from Alto Neuroscience's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.